T. Rowe Price Health Care ETF (TMED) Performance
TMED total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +14.6% since Dec 31, 2025
- 1 year
- +20.0% total return
- Since first price
- +36.3% since 2025
TMED trailing returns vs SPY, QQQ, AGG
| Period | TMED total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | +0.5% | +0.5% | −1.0% | −5.0% | +0.9% |
| 3 months | −0.4% | −0.4% | +3.2% | +1.9% | −0.4% |
| 6 months | +13.1% | +13.1% | +7.8% | +8.4% | −1.5% |
| YTD | +14.6% | +14.6% | +12.3% | +15.1% | −1.0% |
| 1 year | +20.0% | +19.3% | +14.4% | +15.9% | −1.1% |
| Since inceptionJun 12, 2025 | +36.3% | +35.6% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: TMED vs SPY
From Jun 12, 2025: TMED grew to $13,633, SPY to $12,796.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
TMED returns by calendar year
2026 is year to date.
TMED annual returns table
| Year | TMED | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +14.6% | −11.1% | +12.3% | +15.1% | −1.0% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
TMED largest drawdowns
Now 7.1% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Jan 22, 2026 | −11.1% | Mar 27, 2026 | May 28, 2026 | 2 months | 4 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
TMED risk statistics
| Statistic | Since 2025 |
|---|---|
| Annualized return | +29.0% |
| Volatility (annualized) | 15.2% |
| Sharpe ratio | 1.52 |
| Sortino ratio | 3.13 |
| Best month | +7.9% |
| Worst month | −5.1% |
| Best 12 months | +41.8% |
| Worst 12 months | +27.9% |
| Positive months | 60% |
| Beta vs S&P 500 | — |
| Correlation with S&P 500 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
TMED rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 5 | +19.7% | +38.4% | +41.8% | 100% |
Every holding period starting at a month-end since 2025. Returns for 3 years and longer are annualized.
TMED performance overview
T. Rowe Price Health Care ETF (TMED) returned +20.0% over the past year, with distributions reinvested. Since its first recorded price on Jun 12, 2025 it has returned +36.3%. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −11.1%, from Jan 22, 2026 to Mar 27, 2026, and it took 2 months to get back to the old high. Volatility has been 15.2% a year.
Related: TMED chart, TMED holdings, TMED dividends. See the TMED overview for the latest quote and fund facts.
TMED performance FAQ
What is the TMED return over the past year?
TMED returned +20.0% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 19.3%.
How much would $10,000 invested in TMED be worth?
$10,000 invested in TMED at its first recorded close on June 12, 2025 would be worth about $13,633 on October 23, 2026 with distributions reinvested.
What is the biggest drawdown of TMED?
The largest peak-to-trough decline was −11.1% between January 22, 2026 and March 27, 2026. It recovered to the old high on May 28, 2026, 2 months after the bottom.
How volatile is TMED?
Over the past history TMED had an annualized volatility of 15.2% and a Sharpe ratio of 1.52 (excess return over 1–3 month T-bills per unit of risk).